CPD Masters Certificate of Professional Development in Independent Prescribing for Pharmacists | Level 7 (Postgraduate)

The overall aim of the programme is to develop the personal, professional, clinical and diagnostic skills required to deliver person-centred care as a pharmacist independent prescriber.

The course will provide the skills and knowledge required to ensure safe and effective practice as an independent prescriber. Successful completion of the course will demonstrate your competence to allow application for annotation on the General Pharmaceutical Council (GPhC) or Pharmaceutical Society of Northern Ireland's (PSNI) registers as an independent prescriber.

The module comprising the programme covers a range of topics related to practice as an independent prescribing pharmacist and aligns with the GPhC Standards for the education and training of pharmacist independent prescribers (October 2022).

The outline syllabus for the programme is as follows:

• The role of the pharmacist prescriber

• Legal and ethical responsibilities in prescribing

• Equality and diversity in prescribing

• Clinical history taking

• Individual patient variation

• The role of the patient and incorporating patient preferences in prescribing

• Evidence based medicine in clinical decision-making

• Evaluating risks and benefits in clinical decision-making

• Recognising limits of competence

• Patient activation

• Public health in prescribing

• Safeguarding vulnerable patients

• Competence and capacity

• Testing and investigations

• Interpreting and adjusting treatment plans

• Emerging technologies in prescribing

• Record keeping

• Managing influences on the prescribing

• Clinical governance and health economics in prescribing

• Dealing with concerns about own and others prescribing

• Accountability, liability and competence in prescribing

• Other relevant, emerging or pressing concerns relating to prescribing

Study days including assessment days

For September 2026 and March 2027, there will be two sets of study days running due to the maximum capacity permitted on the days. If offered a place on the programme, you will be offered a place on one of these sets of study days. The study days for March 2027 are below. There are a total of seven study days, five are face-to-face campus based study days and two are online.

Group 1

• Wednesday 3rd March 2027 (in-person study day, LJMU Byrom St campus)

• Monday 10th May 2027 (in-person study day, LJMU Byrom St campus)

• Tuesday 11th May 2027 (in-person study day, LJMU Byrom St campus)

• Wednesday 12th May 2027 (in-person study day, LJMU Byrom St campus)

• Thursday 13th May 2027(virtual study day, via Microsoft Teams)

• Monday 28th June 2027 (in-person study day, LJMU Byrom St campus - OSCEs)

• Tuesday 29th June 2027(virtual study day, via Microsoft Teams)

Group 2

• Thursday 4th March 2027 (in-person study day, LJMU Byrom St campus)

•  Monday 17th May 2027 (in-person study day, LJMU Byrom St campus)

• Tuesday 18th May 2027 (in-person study day, LJMU Byrom St campus)

• Wednesday 19th May 2027 (in-person study day, LJMU Byrom St campus)

• Thursday 20th May 2027(virtual study day, via Microsoft Teams)

• Wednesday 30th June 2027 (in-person study day, LJMU Byrom St campus - OSCEs)

• Thursday 1st July 2027 (virtual study day, via Microsoft Teams)

The following are requirements of the programme

• All study days must be attended

• The programme should normally be completed within 12 months of registration

• All assessment must be passed

Course structure

The programme comprises one 40 credit module (7208CPPHAR Independent prescribing for pharmacists). All assessments (see below) and a period of learning in practice (see below) have to be completed successfully in order to be awarded the Masters Certificate of Professional Development (MCPD).

The programme adopts a blended approach to learning and is structured so that students can implement and consolidate their learning in their day-to-day practice. The study days are supplemented by online content and self-directed study. In addition, 90 hours of supervised learning in practice must be completed. At least 45 hours must be completed with a designated prescribing practitioner (DPP).

This programme covers a large amount of learning in a very short space of time. Students need to engage fully with the programme. Over the six months you are required to attend study days (see attendance below) and have enough time to complete self-directed learning, 90 hours of supervised learning in practice as well as assessment preparation.

The programme has two intakes per year in Spring/March and Autumn/September and runs as a standalone course, as well as an embedded option in our Clinical Pharmacy programme:

• Clinical Pharmacy for Secondary and Tertiary Care

Students will be assigned a named tutor at the beginning of your programme who will help to guide you with any queries that you have during the course and can give you formative feedback on assignments and e-portfolio entries. In addition, all students will be supported by a Designated Prescribing Practitioner (DPP), who must be identified before applying for the programme.

Area of practice intended for prescribing training

It is essential that you take time to define your area of practice before applying for the programme. As your clinical experience is assessed in relation to your chosen area of practice during the application and selection process. You may find it helpful to discuss your plans with your line manager, service lead or DPP to ensure that you have a plan in mind and that you can demonstrate your experience in that area in the supplementary application from.

Learning in practice

The programme requires you to demonstrate how their learning is applied in patient-facing prescribing practice through 90 hours of supervised practice. Further, your DPP will assesses your competence to prescribe in a real-world setting at the end of this practice period practice in line with the Royal College of Pharmacy Prescribing Competency Framework. This forms part of the portfolio assessment, please see below.

Attendance

A significant portion of the learning in this programme is undertaken via self-study of online content and discussion with tutors and your DPP. However, students are required to attend the university for seven study days. ALL study days must be attended in order to complete the programme and if absent from any of the study days, an alternate day, which may be some months later, must be attended to complete the course.

Please note that where a student cannot attend a study day, the issue must be identified in advance (wherever possible) so that an alternative study day can be offered. However, alternative study days may be some months later, with the following cohort, and this may delay your completion of the course.

If you are unsure if you can attend the study days before joining the programme, you should look to join a later cohort.

Indemnity Insurance

Pharmacists are generally advised to have professional indemnity insurance in their professional role. Pharmacists undertaking independent prescribing training are advised to check with their insurer that they are fully covered in this role as well as their future role as a qualified prescriber.

• Alternative qualifications considered

  Entrants must:

  • Be a registered pharmacist with the GPhC or the Pharmaceutical Society of Northern Ireland (PSNI).

  • Be in good standing with their regulator.

  • Have relevant clinical and patient-facing experience in a UK pharmacy setting.

  • Have identified an area of clinical practice in which to develop their prescribing skills.

  • Demonstrate the ability to recognise, understand and articulate the skills and attributes required by a prescriber.

  • Have identified a Designated Prescribing Practitioner (DPP) with training and experience appropriate to their role. This may be demonstrated by adherence to the Royal Pharmaceutical Society (now Royal College of Pharmacy) guidance (2019). The DPP must have agreed to provide supervision, support and shadowing opportunities for the student in a patient-facing clinical setting, and be familiar with the GPhC’s requirements of the programme and the need to achieve the learning outcomes.

  • Have a DBS and appropriate liability insurance in place for the period of learning in practice.

  Students will be required to provide acceptable evidence of each of the above and may be interviewed. Letters of support may be required from employers and/or line-managers and/or other healthcare professionals as necessary and appropriate.

To apply for this programme, you are required to complete an LJMU online application form. You will need to provide details of previous qualifications and a personal statement outlining why you wish to study this programme.

A balance of approaches to summative assessment is taken to ensure that the full breadth and depth of the student 's knowledge and skills are assessed, whilst maintaining relevance to the workplace. There are four summative assessments within the programme (see below), which are normally completed within six months of their expected completion date. The period of supervised learning in practice, totalling 90 hours, should be completed within a single 6 month period.

Assessments within 7208CPPHAR Independent prescribing for pharmacists:

Assessments- Weighting

Case series- 60%

Critical reflection- 40%

OSCE- Pass/Fail

Portfolio (including learning in practice declaration)- Pass/Fail

As patient safety is always paramount throughout the programme, all summative assessments need to be passed and no compensation or condonation is allowed. Feedback and opportunities to identify and addresses errors throughout the programme to allow students to learn and train safely. However, students will not complete the programme if they are assessed as being a risk to patients and the public.